MHRA Drug Safety Update August 2019

MHRA Drug Safety Update August 2019

August 20, 2019

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 13 Issue 1 August 2019) has been published and includes articles on:

  • Daratumumab (Darzalex▼): risk of reactivation of hepatitis B virus
  • Naltrexone/bupropion (Mysimba▼): risk of adverse reactions that could affect ability to drive
  • Carfilzomib (Kyprolis▼): reminder of risk of potentially fatal cardiac events
  • Letters and drug alerts sent to healthcare professionals in July 2019
  • Medical Device Alerts issued in July 2019

To see the latest MHRA Drug Safety Update in full, visit the website.

Posted in:

More Latest News >